For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260108:nRSH1811Oa&default-theme=true
RNS Number : 1811O Marwyn Value Investors Limited 08 January 2026
THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR RELEASE,
PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, IN
OR INTO THE UNITED STATES, AUSTRALIA, CANADA, THE REPUBLIC OF SOUTH AFRICA,
JAPAN, ANY MEMBER STATE OF THE EUROPEAN ECONOMIC AREA OR ANY JURISDICTION IN
WHICH IT WOULD BE UNLAWFUL TO DO SO
LEI: 213800L5751QTTVEA774
8th January 2026
MARWYN VALUE INVESTORS LIMITED (THE "COMPANY")
SHARE TRANSFER
The Company announces that it was notified that Peter Rioda, independent
non-executive director of the Company, transferred 10,000 Ordinary Shares from
one of his broker accounts to another on 8th January 2026. Following this
transfer, Peter Rioda's beneficial ownership of Ordinary Shares remains
unchanged at 30,000 Ordinary Shares, representing approximately 0.05% of the
Company's voting rights.
Company enquiries:
Marwyn Value Investors Limited
Scott Danks
scottdanks@marwyn.com
Company Secretary - Palmer Fund Services (Jersey) Limited
marwyn@palmerfs.com
1 Grenville Street
St Helier
Jersey JE2 4UF
Investor Relations - KK Advisory Limited
Kam Bansil
020 7039 1901
PR Adviser - FGS Global
Rollo Head 07768 994987
Chris Sibbald 07855 955531
Corporate Broker - Panmure Liberum Limited
Chris Clarke
0203 100 2200
Shares in the Company are not designed or intended for retail investors.
Marwyn Investment Management LLP, the Manager, does not promote shares in the
Company to retail investors and they should not be offered to retail
investors.
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END DSHFVLFBQFLLBBL
Copyright 2019 Regulatory News Service, all rights reserved